Establishment of a Seven-Gene Signature Associated with CD8+ T Cells through the Utilization of Both Single-Cell and Bulk RNA-Sequencing Techniques in Clear Cell Renal Cell Carcinoma
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241813729 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Yubin Chen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioinformatics, School of Life Sciences, Xuzhou Medical University, Xuzhou 221004, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Carcinoma, Kidney Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Jiangsu Province, Excellent Talents Research Foundation of Xuzhou Medical University.
Abstract (Originalsprache)
Tumor immune microenvironment constituents, such as CD8+ T cells, have emerged as crucial focal points for cancer immunotherapy. Given the absence of reliable biomarkers for clear cell renal cell carcinoma (ccRCC), we aimed to ascertain a molecular signature that could potentially be linked to CD8+ T cells. The differentially expressed genes (DEGs) linked to CD8+ T cells were identified through an analysis of single-cell RNA sequencing (scRNA-seq) data obtained from the Gene Expression Omnibus (GEO) database. Subsequently, immune-associated genes were obtained from the InnateDB and ImmPort datasets and were cross-referenced with CD8+ T-cell-associated DEGs to generate a series of DEGs linked to immune response and CD8+ T cells. Patients with ccRCC from the Cancer Genome Atlas (TCGA) were randomly allocated into testing and training groups. A gene signature was established by conducting LASSO-Cox analysis and subsequently confirmed using both the testing and complete groups. The efficacy of this signature in evaluating immunotherapy response was assessed on the IMvigor210 cohort. Finally, we employed various techniques, including CIBERSORT, ESTIMATE, ssGSEA, and qRT-PCR, to examine the immunological characteristics, drug responses, and expression of the signature genes in ccRCC. Our findings revealed 206 DEGs linked to immune response and CD8+ T cells, among which 65 genes were correlated with overall survival (OS) in ccRCC. A risk assessment was created utilizing a set of seven genes: RARRES2, SOCS3, TNFSF14, XCL1, GRN, CLDN4, and RBP7. The group with a lower risk showed increased expression of CD274 (PD-L1), suggesting a more favorable response to anti-PD-L1 treatment. The seven-gene signature demonstrated accurate prognostic prediction for ccRCC and holds potential as a clinical reference for treatment decisions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Bioinformatics, School of Life Sciences, Xuzhou Medical University, Xuzhou 221004, China.
- Department of Biophysics, School of Life Sciences, Xuzhou Medical University, Xuzhou 221004, China.
ORCID-Profile: Wenlong Du
Förderung
- Natural Science Foundation of Jiangsu Province
- Excellent Talents Research Foundation of Xuzhou Medical University
Zitieren
APA
Chen, Y., Zhou, X., Xie, Y., Wu, J., Li, T., Yu, T., Pang, Y., & Du, W. (2023). Establishment of a Seven-Gene Signature Associated with CD8+ T Cells through the Utilization of Both Single-Cell and Bulk RNA-Sequencing Techniques in Clear Cell Renal Cell Carcinoma. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241813729
Vancouver
Chen Y, Zhou X, Xie Y, Wu J, Li T, Yu T, et al. Establishment of a Seven-Gene Signature Associated with CD8+ T Cells through the Utilization of Both Single-Cell and Bulk RNA-Sequencing Techniques in Clear Cell Renal Cell Carcinoma. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241813729
BibTeX
@article{Chen2023,
author = {Chen, Yubin and Zhou, Xinyu and Xie, Yanwei and Wu, Jianan and Li, Tingting and Yu, Tian and Pang, Yipeng and Du, Wenlong},
title = {Establishment of a Seven-Gene Signature Associated with CD8+ T Cells through the Utilization of Both Single-Cell and Bulk RNA-Sequencing Techniques in Clear Cell Renal Cell Carcinoma},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241813729}
}
EUVIMED